Quantcast

Latest Foundation Fighting Blindness Stories

2013-05-30 23:00:55

Alex Brown and Erin Gillen join Kim Power Stilson on the TalkWorthy Radio Show to talk about the Utah Vision Walk. Blinding retinal degenerative diseases like retinitis pigmentosa, macular degeneration and Usher syndrome affect more than 10 million Americans, but the Foundation Fighting Blindness is funding cutting-edge studies toward preventions, treatments and cures. Salt Lake City, UT (PRWEB) May 30, 2013 Alex Brown and Erin Gillen, spokespersons for the 5th Annual Utah 5K VisionWalk on...

2013-01-16 23:03:36

Jan. 17 Event Will Honor Key Food Chief Executive; Special Guest Mrs. World Queens, NY (PRWEB) January 16, 2013 The Foundation Fighting Blindness, a national nonprofit that drives sight-saving research, will host its 2nd Annual ℠Una Visión Para El Futuro´ (A Vision for the Future) on Thursday, Jan. 17, at Terrace on the Park in Flushing Meadows Park. The event will honor the accomplishments and community involvement of Key Food Chief Executive Dean Janeway, as supermarket...

2012-12-04 15:00:32

Biologists at Mainz University achieve repair and read-through of stop mutations responsible for the disease After years of basic research, scientists at Johannes Gutenberg University Mainz (JGU) are increasingly able to understand the mechanisms underlying the human Usher syndrome and are coming ever closer to finding a successful treatment approach. The scientists in the Usher research group of Professor Dr. Uwe Wolfrum are evaluating two different strategies. These involve either the...

2012-01-23 22:46:02

A new gene therapy method developed by University of Florida researchers has the potential to treat a common form of blindness that strikes both youngsters and adults. The technique works by replacing a malfunctioning gene in the eye with a normal working copy that supplies a protein necessary for light-sensitive cells in the eye to function. The findings are published today (Monday, Jan. 23) in the Proceedings of the National Academy of Sciences online. Several complex and costly steps...

2011-06-22 01:00:00

OXFORD, England, June 22, 2011 /PRNewswire/ -- - RetinoStat(R) Progress in Phase I Study in Wet Age-Related Macular Degeneration Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), a leading gene therapy company, today announces that the first dose level of RetinoStat(R) is safe and well-tolerated at one month following treatment. RetinoStat(R) is a novel gene-based treatment for neovascular "wet" age-related macular degeneration (AMD), designed and...

216f1e2c8e43683d7c2bda043fb9a614
2011-06-17 12:40:00

The first two patients with common but incurable diseases of the eye that can lead to blindness have been enrolled early in a two phase groundbreaking clinical trial of therapy that researchers are hoping will heal the damage caused by the conditions. Advanced Cell Technology Inc. (ACT) announced Thursday the enrollment of the patients in the trials for Stargardt's Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration (Dry AMD). The patients were enrolled at the Jules Stein Eye...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related